Mitsubishi Tanabe Looks To Maximize Generic Sales Through New Unit
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Mitsubishi Tanabe Pharma plans to launch Tanabe Pharmaceutical sales company on April 1. Established on the basis of the company's current marketing division, Tanabe Pharmaceutical Trading, the new company will market MTP's 14 generic drugs with a plan to expand to 60-140 drugs and a sales goal of ¥10 billion. MTP focuses its generic drug business on circulatory and digestive pharmaceutical products. (Click here for more - Japanese language
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.